# K110067: LP Cage

- Pathway: 510(k) (Traditional)
- Applicant: Medyssey Co, Ltd.
- Decided: Apr 8, 2011 after 88 days
- Product code: MAX (Intervertebral Fusion Device With Bone Graft, Lumbar)
- Device class: 2
- Regulation: 21 CFR 888.3080
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to P950002 (1996). 5 ancestors in all.
15 later devices descend from it; 5 cite it directly.
0 of 21 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K072226: Impix Spacer, Medicrea Technologies (2007) Summary page 1.

## Most influential descendants
- K120464: Innesis Peek Cage (2013), 6 descendants of its own
- K170341: Medussa-PL Cage (2017), 4 descendants of its own
- K140564: BN Lumbar Cage System (2014), 3 descendants of its own
- K140577: Innesis Peek TL Cage (2014), 2 descendants of its own
- K121246: Medyssy LT Cage System (2012), 2 descendants of its own

## Indications for use
The LP Cage is indicated for use in skeletally mature patients with Degenerative Disc Disease (DDD) at one or two contiguous levels from L2-S1. DDD is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies. Patients should have received 6 months of non-operative treatment prior to treatment with the devices. The device must be used with supplemental fixation. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). It is indicated to be used with autograft bone.

Source page: https://510kreport.com/device/K110067
Methodology: https://510kreport.com/methodology